Investors

|

Portal
Order

Caris Detect™ Multi-Cancer Early Detection Test Now Available.

Learn More
Home / Research / Artificial Intelligence / Nanoverse

Innovation

Caris Nanoverse

Exploring the Biological Nanoverse to Better Detect, Categorize and Inform Healthcare

Through the power of AI and vast amounts of molecular data, Caris has developed a revolutionary mechanism to unravel the biological complexity of diseases. The Caris Nanoverse™ provides physicians and researchers a new way to identify patient populations, predict therapy responses and identify targets for drug development in ways never before possible.

Informing a Molecular Revolution in Medicine

Nestled deep in our molecular coding is a universe of biological networks that provide the source of life. From how our cells grow, divide and even die, this biological web holds the keys to better detect, categorize and inform healthcare in an entirely new way. Discover how Caris is pushing the boundaries of what is possible and leading a molecular revolution in medicine.

Driving Molecular Science Innovation

1.0+ Million

Cases

6.5+ Million

Tests

50+ Billion

Molecular Markers Measured

Discover
More

Publications

Caris Life Sciences contributes to the body of research in oncology to advance the understanding of molecular science and further enable the delivery of precision medicine.

Artificial Intelligence

With one of the largest, multi-modal databases of combined molecular and clinical outcomes data in the world, Caris applies highly sophisticated AI bioinformatics and machine learning capabilities on this massive database to create novel, clinically relevant solutions to classify cancer at the molecular level and predict patient response in ways never before possible.

Contact Us

Have questions?